89bio, Inc.
ETNB
$8.11
$0.415.33%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -386.67M | -367.08M | -288.96M | -174.61M | -165.03M |
| Total Depreciation and Amortization | 39.00K | 38.00K | 45.00K | 47.00K | 45.00K |
| Total Amortization of Deferred Charges | 1.12M | 831.00K | 684.00K | 748.00K | 817.00K |
| Total Other Non-Cash Items | 15.82M | 12.92M | 11.90M | 9.86M | 10.01M |
| Change in Net Operating Assets | -30.15M | -14.53M | -4.20M | -1.58M | 15.34M |
| Cash from Operations | -399.84M | -367.82M | -280.54M | -165.54M | -138.82M |
| Capital Expenditure | -87.00K | -15.00K | -4.00K | -4.00K | -4.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 31.29M | -40.85M | -124.33M | -77.36M | -207.02M |
| Cash from Investing | 31.20M | -40.86M | -124.33M | -77.37M | -207.02M |
| Total Debt Issued | 9.35M | 9.35M | 9.35M | 0.00 | 0.00 |
| Total Debt Repaid | -- | -- | 0.00 | 0.00 | 0.00 |
| Issuance of Common Stock | 459.10M | 212.14M | 237.75M | 213.12M | 216.02M |
| Repurchase of Common Stock | -1.99M | -2.65M | -2.63M | -3.32M | -3.28M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | -253.00K | -116.00K | -116.00K | -253.00K |
| Cash from Financing | 466.46M | 218.59M | 244.35M | 209.68M | 212.49M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 97.82M | -190.10M | -160.52M | -33.22M | -133.36M |